Shum, Jenny
January 2010
Boston College International & Comparative Law Review;Winter2010, Vol. 33 Issue 1, p153
Academic Journal
Human embryonic stem cells have unique regenerative properties and the ability to develop into a variety of different cell types. Based on these properties, stem cell research is considered a promising biomedical field for the development of cell-based therapies to treat diseases. It is also a highly contentious field because these cells are derived from human embryos. The United States, unlike the European Union, does not have a moral component to the patent grant process and has granted several stem cell patents. This Note examines the intersection of these broad patents and U.S. policies limiting stem cell research funding and highlights their deleterious effects on the progress of human embryonic stem cell research. This Note also evaluates the feasibility of incorporating ethical criteria, as used in the European Union, for U.S. patent grants and concludes that uniform moral standards would be impossible to determine and effectuate for this process.


Related Articles

  • Political Interventions in U.S. Human Embryo Research: An Ethical Assessment. Green, Ronald M. // Journal of Law, Medicine & Ethics;Summer2010, Vol. 38 Issue 2, p220 

    For more than 30 years, beginning with the Reagan administration's refusal to support and provide oversight for embryo research, and continuing to the present in congressionally imposed limits on funding for such research, progress in infertility medicine and the development of stem cell...

  • A stem cell ban is lifted, but some states see a heavy backlash. Dorans, Kirsten // Nature Medicine;Apr2009, Vol. 15 Issue 4, p347 

    The article reports that several U.S. states limit the funding of research on embryonic stem cell lines despite U.S. President Barack Obama's rescission of the executive order of the former administration. Louisiana has a law that forbids research that involves destruction of human embryos while...

  • Take stand for stem cell research.  // Crain's Detroit Business;6/14/2010, Vol. 26 Issue 24, p6 

    The article analyzes the difference of opinion among lawmakers in Michigan on whether to allow research that uses embryonic stem cells.

  • INTRODUCTION. Robertson, John A. // Journal of Law, Medicine & Ethics;Summer2010, Vol. 38 Issue 2, p175 

    An introduction to the journal is presented in which the author discusses an overview of the embryonic stem cell (ESC) controversy by John Robertson, study on innovative therapy and stem cells from a more theoretical perspective by Patrick Taylor, and an essay on scientific complexity of the...

  • Media Miss Point About Stem Cells. Hickey, Jennifer G. // Insight on the News;7/30/2001, Vol. 17 Issue 28, p20 

    Reports on the congressional hearings regarding the legality and ethical aspects of conducting research on stem cells extracted from human embryos. Details on the possible benefits of the research in treating debilitating diseases; Opinion of religious groups on the issue; Views concerning...

  • Regenerative Medicine and Stem Cells: Prometheus Revisited. Bouros, Demosthenes; Laurent, Geoff // Respiration;2012, Vol. 85 Issue 1, p1 

    No abstract available Copyright © 2012 S. Karger AG, Basel

  • Murgitroyd Expands in Munich, Patent Capital of Europe.  // Biomedical Market Newsletter;8/7/2012, Vol. 21, p1 

    The article informs that Murgitroyd & Co. is expanding its operations in Munich, Germany for the establishment of the European Unitary Patent. It informs about the aim of the expansion which is to boost the value of patent protection by making it cheaper and faster for enforcing European...

  • Judge halts US funding of stem cell research. Roehr, Bob // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;9/4/2010, Vol. 341 Issue 7771, p477 

    The article focuses on a decision issued by Judge Royce Lamberth on August 23, 2010, which immediately halted all U.S. government funding for research using embryonic stem cell pending the outcome of a trial into the legality of such funding.

  • REGULATING DEVELOPMENTS IN EMBRYONIC STEM CELL RESEARCH IN AFRICA: A THIRD PERSON'S PERSPECTIVE. Amechi, Emeka Polycarp // African Journal of International & Comparative Law;Mar2007, Vol. 15 Issue 1, p85 

    The article presents a discussion of regulating developments in embryonic stem cell research in Africa, adapted from the research report "What Types of Regulations Should Guide the Ongoing Developments in Embryonic Stem Cells Research?," by Emeka Polycarp Amechi.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics